Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia, Int Psychogeriatr, vol.24, pp.1034-1079, 2012. ,
Survival in dementia and predictors of mortality: a review, Int J Geriatr Psychiatry, vol.28, pp.1109-1133, 2013. ,
Characterization of dementia and Alzheimer's disease in an older population: updated incidence and life expectancy with and without dementia, Am J Public Health, vol.105, pp.408-421, 2015. ,
, Alzheimer's disease facts and figures, Alzheimers Dement, vol.12, pp.459-509, 2016.
Contribution of Alzheimer disease to mortality in the United States, Neurology, vol.82, pp.1045-50, 2014. ,
Deaths from Alzheimer's disease -United States, MMWR Morb Mortal Wkly Rep, vol.66, pp.521-527, 1999. ,
Diagnosed depression and sociodemographic factors as predictors of mortality in patients with dementia, Br J Psychiatry, vol.213, pp.471-477, 2018. ,
Effect of vascular risk factors and diseases on mortality in individuals with dementia: a systematic review and meta-analysis, J Am Geriatr Soc, vol.64, pp.37-46, 2016. ,
Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, J Neuropathol Exp Neurol, vol.71, pp.266-73, 2005. ,
Biomarkers for Alzheimer's disease: current status and prospects for the future, J Intern Med, vol.284, pp.643-63, 2018. ,
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, pp.263-272, 2011. ,
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, vol.13, pp.614-643, 2014. ,
NIA-AA research framework: toward a biological definition of Alzheimer's disease, Alzheimers Dement, vol.14, pp.535-62, 2018. ,
A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers, Neurology, vol.87, pp.539-586, 2016. ,
Distribution of cerebrospinal fluid biomarker profiles in patients explored for cognitive disorders, J Alzheimers Dis, vol.64, pp.889-97, 2018. ,
Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting, Alzheimers Dement, vol.9, pp.406-419, 2013. ,
Cerebrospinal fluid amyloid-beta 42/40 ratio in clinical setting of memory centers: a multicentric study, Alzheimers Res Ther, vol.7, p.30, 2015. ,
CSF biomarker variability in the Alzheimer's Association quality control program, Alzheimers Dement, vol.9, pp.251-61, 2013. ,
The screening of Alzheimer's patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trials, J Neurol, vol.261, pp.1187-95, 2014. ,
High tau levels in cerebrospinal fluid predict rapid decline and increased dementia mortality in Alzheimer's disease, Dement Geriatr Cogn Disord, vol.37, pp.196-206, 2014. ,
Disease-related determinants are associated with mortality in dementia due to Alzheimer's disease, Alzheimers Res Ther, vol.10, p.23, 2018. ,
Genetic factors associated with longevity: a review of recent findings, Ageing Res Rev, vol.19, pp.1-7, 2015. ,
Apolipoprotein E genotypes and longevity across dementia disorders, Alzheimers Dement, vol.14, pp.895-901, 2018. ,
Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality, Neurology, vol.90, pp.1920-1928, 2018. ,
Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain, Arch Neurol, vol.66, pp.382-391, 2009. ,
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings, Neurology, vol.78, pp.1568-75, 2012. ,
Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta-amyloid, Ann Neurol, vol.74, pp.826-862, 2013. ,
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease, Neurology, vol.85, pp.1240-1249, 2015. ,
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins, Lancet, vol.363, pp.1139-1185, 2004. ,
The overlap between vascular disease and Alzheimer's disease--lessons from pathology, BMC Med, vol.12, p.206, 2014. ,
Expression and processing of amyloid precursor protein in vascular endothelium, Physiology (Bethesda), vol.32, pp.20-32, 2017. ,
Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease, Cardiovasc Hematol Disord Drug Targets, vol.6, pp.21-34, 2006. ,
Plasma beta-amyloid 40 levels are positively associated with mortality risks in the elderly, Alzheimers Dement, vol.11, pp.672-80, 2015. ,
Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease, J Am Coll Cardiol, vol.65, pp.904-920, 2015. ,
Alzheimer's disease drug development pipeline, Alzheimers Dement (N Y), vol.4, pp.195-214, 2018. ,
Trial of solanezumab for mild dementia due to Alzheimer's disease, N Engl J Med, vol.378, pp.321-351, 2018. ,